Diligence memo · auto-generated · as of July 1, 2026
Neosync Inc
Neosync Inc looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Neosync Inc operates in Healthtech, based in SOUTH BOSTON, CA, USA. Neosync is an open-source anonymization and synthetic data platform.
Sub-sector tags: B2B, Developer Tools, SaaS, ai/ml, data/analytics, fintech, healthtech.
Capital & rounds (filed)filed
Neosync Inc has raised $12M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $9.0M on 2017-06-13.
Most recent recorded round closed around 2017-06-13.
Valuation (modeled)modeled
Provath models Neosync Inc at approximately $203M (range $12M–$1.1B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.52× the median modeled value of Series A Healthtech companies in 2016–2018 (103 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 84 months.
Last raise 9.0 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 2.6× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 73% of Healthtech peers (2138 compared).
Modeled value ranks above 86% of those peers.
Closest niche peers: HealthMyne, Inc., Prenexus Health, LLC, Companion Medical, Inc., Health at Scale Corp, Motus GI Medical Technologies, Ltd..
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.